Body Composition
Explore compounds linked with appetite, weight management, fat distribution and body composition. The evidence ranges from established medicines to earlier research candidates.
Explore the area, then follow the evidence. These compounds appear here because they are studied or commonly discussed in this category. Open a profile to see what the research actually supports.
Explore body composition
The compounds with complete profiles, brought together around the reasons people are interested in this area.
Semaglutide
GLP-1 receptor agonist with extensive human weight-management evidence.
Tirzepatide
Dual GIP and GLP-1 receptor agonist with extensive clinical evidence.
Retatrutide
Investigational GIP, GLP-1 and glucagon triple-receptor agonist.
Cagrilintide
Long-acting amylin analogue studied alone and with semaglutide.
Tesamorelin
GHRH analogue with human research involving visceral fat in a defined clinical population.
AOD-9604
Growth-hormone fragment investigated for metabolic and fat-related effects.